Physician profile
Thomas Meade
NPI 1275525917
$411,160.65
in general payments reported to CMS, 2019-2025
16 companies · $26K in 2025
The $26K reported for 2025 was more than what 83% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101K · 2020: $78K · 2021: $68K · 2022: $51K · 2023: $47K · 2024: $41K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $59K · Consulting Fee: $49K · Travel and Lodging: $2,728 · Food and Beverage: $2,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $59,115.40 |
| Consulting Fee | $48,952.95 |
| Travel and Lodging | $2,728.48 |
| Food and Beverage | $2,352.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $349,871.66 | 2019-2025 | Arthrex |
| Exactech, INC. | $51,432.93 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $3,215.50 | 2019 | |
| Novus Surgical Solutions LLC | $2,400.00 | 2021-2022 | |
| Heron Therapeutics, INC. | $1,500.00 | 2020 | |
| Novus Surgical Consultants | $612.26 | 2023-2024 | |
| Stryker Corporation | $564.93 | 2020-2025 | Triathlon |
| Medacta USA, INC. | $553.23 | 2020-2023 | Gmk Sphere |
| Kci USA, INC. | $492.98 | 2019 | |
| Davol INC. | $126.25 | 2023 | |
| Pacira Therapeutics, INC. | $115.77 | 2019 | |
| Arthrosurface Incorporated | $107.16 | 2019 | |
| Aesculap Implant Systems, LLC | $60.95 | 2019 | |
| Medical Device Business Services, INC. | $50.00 | 2022 | |
| Boston Scientific Corporation | $45.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Meade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.